Approval · Notice of Compliance 595 · 2002
INTRON A: Notice of Compliance 595
Issued September 13, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 595
- Date
- September 13, 2002
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTRON A | 02223406 | Cancelled Post Market |
Medicinal ingredients
- INTERFERON ALFA 2B 10,000,000 UNIT per VIAL
- WATER 2 ML per VIAL